Status:
WITHDRAWN
Efficacy of Stellate Ganglion Block in Children With Cerebral Palsy and Dysphagia
Lead Sponsor:
Zeng Changhao
Conditions:
Cerebral Palsy
Eligibility:
All Genders
4-7 years
Phase:
NA
Brief Summary
The goal of this clinical trial is to test the efficacy of stellate ganglion block in children with cerebral palsy and dysphagia. The main question it aims to answer are: • Can stellate ganglion bloc...
Detailed Description
Cerebral palsy is a common non-progressive clinical condition characterized by motor disorders and abnormal postures, which significantly impact the quality of life of affected children. Swallowing dy...
Eligibility Criteria
Inclusion
- meeting the diagnostic criteria of cerebral palsy formulated by the 13th National Conference on Pediatric Cerebral Palsy Rehabilitation;
- age between 4 to 7 years;
- diagnosed as dysphagia confirmed by Dysphagia Disorder Survey or pediatric esophagoscopy;
Exclusion
- with dysphagia caused by other diseases or factors;
- with progressive neurological disease or degenerative neurological disease;
- with severe heart disease, liver or kidney dysfunction, hematological disorders, or other acute and severe symptoms;
- with abnormalities in the oral cavity, pharynx, esophagus, or other parts of the digestive tract;
- with poor compliance.
Key Trial Info
Start Date :
January 15 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 30 2024
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT06211426
Start Date
January 15 2024
End Date
April 30 2024
Last Update
March 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zheng da yi fu yuan hospital
Zhengzhou, Henan, China, 450000